VRTX and MRK Related Headlines
Go Back- Bernstein on US Pharma and Biotech: Who might buy whom?
- RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
- BofA unveils its top 10 U.S. ideas for Q1 2026
- BofA: 'our Top 10 Ideas include nine Buys and one Underperform across nine industries'
